6 Months' Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer.

Authors :: Ussia GP
Mangieri A
Cammalleri V
Sarkar K
Regazzoli D
Cozzi O
Gitto M
Francone M
Fumero A
Torracca L
Bragato RM
Civilini E
Reimers B
Colombo A
Source :: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2024 Jun 24; Vol. 17 (12), pp. 1500-1501. Date of Electronic Publication: 2024 Apr 17.
Publication Year :: 2024
Abstract: Competing Interests: Funding Support and Author Disclosures Dr Mangieri serves as proctor for P+F Products+Features GmbH and Kardia; has received an institutional grant from Boston Scientific; and has received speaker honoraria from Boston Scientific, Concept Medical, Edwards Lifesciences, and Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Subjects :: Humans
Treatment Outcome
Time Factors
Cardiac Catheterization instrumentation
Male
Tricuspid Valve Insufficiency surgery
Tricuspid Valve Insufficiency physiopathology
Tricuspid Valve Insufficiency diagnostic imaging
Hemodynamics
Aged
Heart Valve Prosthesis
Tricuspid Valve surgery
Tricuspid Valve physiopathology
Tricuspid Valve diagnostic imaging
Heart Valve Prosthesis Implantation instrumentation
Heart Valve Prosthesis Implantation adverse effects
Prosthesis Design

Full Text Access

Tools